MARKET

INO

INO

Inovio Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.510
0.000
0.00%
After Hours: 2.510 0 0.00% 16:00 09/18 EDT
OPEN
2.500
PREV CLOSE
2.510
HIGH
2.540
LOW
2.410
VOLUME
377.92K
TURNOVER
--
52 WEEK HIGH
6.30
52 WEEK LOW
2.030
MARKET CAP
248.56M
P/E (TTM)
-2.0694
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of INO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

INO News

  • Odds Not In Our Favor With Inovio Pharmaceuticals
  • Seeking Alpha - Article.1d ago
  • Inovio nabs $4.6M in NIH funding for antimicrobial resistance research
  • seekingalpha.1d ago
  • Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infection
  • PR Newswire.1d ago
  • Inovio Reports Received $4.6M NIH Funding To Target dMAb Technology Against Antimicrobial-Resistant Infection
  • Benzinga.1d ago

More

Industry

Biotechnology & Medical Research
-0.68%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About INO

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.
More

Webull offers Inovio Pharmaceuticals Inc (INO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.